Prevalence of HER2 overexpression in gastric adenocarcinoma and its clinicopathological correlation: a prospective study from Bir Hospital, Nepal
{{output}}
Background: Gastric adenocarcinoma remains a leading cause of cancer-related mortality in Nepal. Trastuzumab, in the ToGA trial, has been shown to improve overall survival in HER2-overexpressing patients, with overexpression obse... ...
